- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02069587
Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes
February 20, 2014 updated by: Hillel Yaffe Medical Center
Preterm premature rupture of membrane is associated with increased oxidative stress and inflammatory process, enhancing the activity or the availability of antioxidants may modulate the inflammatory response associated with PPROM, thereby reducing oxidative stress and the risk to the fetus.
In this study the investigators sought to determine the effects of Pomegranate 1.
On the patients (maternal and fetal) oxidative stress and inflammation associated with PPROM.
2. On the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores
Study Overview
Detailed Description
In this study the investigators sought to determine the effects of Pomegranate 1.
On the patients (maternal and fetal )oxidative stress and inflammation associated with PPROM.
2. On the time interval from PPROM to delivery and on the patients (fetal )Ph and apger scores
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: ron beloosesky, M.D
- Phone Number: 011972509205759
- Email: tomor2304@yahoo.com
Study Locations
-
-
-
Hadera, Israel, 38100
- Hillel Yaffe Medical Center
-
Contact:
- Ron Balosesky, MD
- Phone Number: 972509205759
- Email: tomor2304@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 44 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant patients
- admitted with PPROM
- between 24-32 weeks of gestation
Exclusion Criteria:
- Women with contractions
- abruption
- monochorionic multiple pregnancy
- abnormal (non-reassuring) cardiotocogram
- meconium-stained amniotic fluid
- signs of intrauterine infection
- major fetal anomalies
- hemolysis
- elevated liver enzymes
- low platelets (HELLP syndrome); or severe preeclampsia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pomegranate
The women in this group will drink pomegranate juice
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal and fetal oxidative stress
Time Frame: 10 weeks
|
Maternal and fetal oxidative stress will be determined by blood tests.
|
10 weeks
|
Maternal and fetal oxidative stress
Time Frame: 10 weeks
|
Maternal blood and umbilical cord blodd will be drawn following delivery and oxidative blood markers inflammatory mediators will be assessed
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time interval from PPROM to delivery
Time Frame: 10 weeks
|
Time interval from PPROM to delivery, respiratory distress syndrome (RDS), meconium aspiration syndrome, asphyxia, late onset neonatal sepsis, hypoglycemia, necrotizing enterocolitis, hyperbilirubinemia, intraventricular hemorrhage, periventricular leucomalacia, convulsions, other neurological abnormalities, other complications, intrapartum death, total length of hospital stay and admission, and length of stay on neonatal intensive care unit (NICU).
|
10 weeks
|
time interval from PPROM to delivery
Time Frame: 10 weeks
|
following birth the time interval from PPROM to delivey will be assessed, also RDS, fetal Ph and other neonatal complications
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: ron beloosesky, Hillel Yaffe Medical center technion
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Anticipated)
February 1, 2015
Study Completion (Anticipated)
April 1, 2015
Study Registration Dates
First Submitted
February 16, 2014
First Submitted That Met QC Criteria
February 20, 2014
First Posted (Estimate)
February 24, 2014
Study Record Updates
Last Update Posted (Estimate)
February 24, 2014
Last Update Submitted That Met QC Criteria
February 20, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0074-13HYMC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PPROM
-
Mennatallah Mohamed ElnemrUnknownAim is to Investigate Association Between Lactate Concentration in Vaginal Fluid and Time of Spontaneous Onset of Labor in PPROMEgypt
-
Université de SherbrookeLaval UniversityUnknown
-
Washington University School of MedicineRecruiting
-
The University of Texas Medical Branch, GalvestonRecruitingPreterm Premature Rupture of Membranes (PPROM)United States
-
Seoul National University HospitalCompletedPreterm Labor | Preterm Premature Rupture of Membrane (PPROM)Korea, Republic of
-
Christina Chianis ReedThe Methodist Hospital Research InstituteRecruitingMusic Therapy | Preterm Premature Rupture of Membrane (PPROM)United States
-
Jena University HospitalCenter of Fetal Surgery, University Hospital Halle Saale; Section for Neonatology...Recruiting
-
Washington University School of MedicineRecruitingPregnancy Complications | Pregnancy Loss | Fetal Death | Abortion, Second Trimester | Fetal Demise | Rupture, Spontaneous | PPROM | Fetal Demise From Miscarriage | Fetal Death Before 22 Weeks With Retention of Dead FetusUnited States
-
University of PennsylvaniaCompletedWomen Admitted to Labor and Delivery for the Management of Preterm Labor and/or Preterm Premature Rupture of Membranes (PPROM)United States
-
The University of Texas Medical Branch, GalvestonTerminatedPPROM | Respiratory Distress Syndrome in Premature InfantsUnited States
Clinical Trials on pomegranate
-
National Research Council, SpainHospital Universitario Reina Sofia de CordobaCompletedColorectal CancerSpain
-
Dalin Tzu Chi General HospitalCompletedHearing ImpairmentTaiwan
-
University of California, Los AngelesCompletedSkin Photoaging, Inflammation and Skin Pathogenic BacteriaUnited States
-
University of California, Los AngelesCompletedCardiovascular Diseases
-
Jonsson Comprehensive Cancer CenterCompletedProstate CancerUnited States
-
Roll International CorporationUnknownProstate CancerUnited States
-
University of WashingtonCompletedInflammation | Cardiovascular Disease | End Stage Renal DiseaseUnited States
-
University of LeedsCompletedHyperglycaemiaUnited Kingdom
-
National Research Council, SpainUniversidad Católica San Antonio de Murcia; The Scientific and Technological...Completed
-
National Research Council, SpainIMDEA Food; CEIP (primary school) Jara Carrillo (Alcantarilla, Murcia, Spain); IES (secondary school) Alcántara (Alcantarilla, Murcia, Spain)CompletedGenotype, Metabotype and Dietary HabitsSpain